{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:34:14Z","timestamp":1790505254333,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG032438"],"award-info":[{"award-number":["U19AG032438"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010773","name":"Demensf\u00f6rbundet","doi-asserted-by":"publisher","award":["2017"],"award-info":[{"award-number":["2017"]}],"id":[{"id":"10.13039\/100010773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"crossref","award":["2015-NIRG-339824"],"award-info":[{"award-number":["2015-NIRG-339824"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004200","name":"Stiftelsen Olle Engkvist Byggm\u00e4stare","doi-asserted-by":"publisher","award":["184-333"],"award-info":[{"award-number":["184-333"]}],"id":[{"id":"10.13039\/501100004200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","award":["2015-04905"],"award-info":[{"award-number":["2015-04905"]}],"id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0624-z","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T08:37:12Z","timestamp":1543221432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["The relevance of cerebrospinal fluid \u03b1-synuclein levels to sporadic and familial Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"6","author":[{"name":"for the Dominantly Inherited Alzheimer Network (DIAN)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Twohig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rodriguez-Vieitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid B.","family":"Sando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guro","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Lauridsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f8ril R.","family":"Gr\u00f8ntvedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Br\u00e5then","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalicharan","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammie L. S.","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste M.","family":"Karch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Nordberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda R.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta M.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"624_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0006-8993(00)03082-1","volume":"888","author":"Y Arai","year":"2001","unstructured":"Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y (2001) \u03b1-Synuclein-positive structures in cases with sporadic Alzheimer\u2019s disease: morphology and its relationship to tau aggregation. Brain Res 888:287\u2013296 Elsevier","journal-title":"Brain Res"},{"key":"624_CR2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nm.3885","volume":"21","author":"T Bachhuber","year":"2015","unstructured":"Bachhuber T, Katzmarski N, McCarter JF, Loreth D, Tahirovic S, Kamp F et al (2015) Inhibition of amyloid-\u03b2 plaque formation by \u03b1-synuclein. Nat Med 21:802\u2013807 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved","journal-title":"Nat Med"},{"key":"624_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt59","volume":"3","author":"RJ Bateman","year":"2011","unstructured":"Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM et al (2011) Autosomal-dominant Alzheimer\u2019s disease: a review and proposal for the prevention of Alzheimer\u2019s disease. Alzheimers Res Ther 3:1 BioMed Central","journal-title":"Alzheimers Res Ther"},{"key":"624_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC et al (2012) Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med 367:795\u2013804 Massachusetts Medical Society","journal-title":"N Engl J Med"},{"key":"624_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JAD-150234","volume":"49","author":"G Berge","year":"2015","unstructured":"Berge G, Lauridsen C, Sando SB, Holder DJ, M\u00f8ller I, Aasly JO et al (2015) Effect of Tween-20 on Core biomarkers measured in cerebrospinal fluid from patients with Alzheimer\u2019s disease, mild cognitive impairment, or healthy control individuals. J Alzheimer\u2019s Dis 49:493\u2013502 IOS Press","journal-title":"J Alzheimer\u2019s Dis"},{"key":"624_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12883-016-0706-0","volume":"16","author":"G Berge","year":"2016","unstructured":"Berge G, Sando SB, Albrektsen G, Lauridsen C, M\u00f8ller I, Gr\u00f8ntvedt GR et al (2016) Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer\u2019s disease, mild cognitive impairment, or healthy controls: a two year follow-up study. BMC Neurol BioMed Central 16:180","journal-title":"BMC Neurol BioMed Central"},{"key":"624_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/jnnp-2013-307228","volume":"85","author":"G Berge","year":"2014","unstructured":"Berge G, Sando SB, Rongve A, Aarsland D, White LR (2014) Apolipoprotein E \u03b52 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort. J Neurol Neurosurg Psychiatry 85:1227\u20131231 BMJ Publishing Group Ltd","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"624_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","volume":"12","author":"VW Chow","year":"2010","unstructured":"Chow VW, Mattson MP, Wong PC, Gleichmann M (2010) An overview of APP processing enzymes and products. NeuroMolecular Med 12:1\u201312 Humana Press Inc","journal-title":"NeuroMolecular Med"},{"key":"624_CR9","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30:7281\u20137289","journal-title":"J Neurosci"},{"key":"624_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261:921\u2013923 American Association for the Advancement of Science","journal-title":"Science"},{"key":"624_CR11","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/syn.21566","volume":"66","author":"SA Eisenstein","year":"2012","unstructured":"Eisenstein SA, Koller JM, Piccirillo M, Kim A, Antenor-Dorsey JAV, Videen TO et al (2012) Characterization of extrastriatal D2 in vivo specific binding of [18F](N-methyl)benperidol using PET. Synapse 66:770\u2013780 NIH Public Access","journal-title":"Synapse"},{"key":"624_CR12","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH et al (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30:6838\u20136851 Society for Neuroscience","journal-title":"J Neurosci"},{"key":"624_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"AM Fagan","year":"2006","unstructured":"Fagan AM, Mintun MA, Mach RH, Lee S-Y, Dence CS, Shah AR et al (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid A\u03b2 42 in humans. Ann Neurol 59:512\u2013519 Wiley-Blackwell","journal-title":"Ann Neurol"},{"key":"624_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C et al (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341\u2013355","journal-title":"Neuron"},{"key":"624_CR15","doi-asserted-by":"crossref","unstructured":"G\u0105ssowska M, Czapski GA, Paj\u0105k B, Cie\u015blik M, Lenkiewicz AM, Adamczyk A. Extracellular \u03b1-Synuclein Leads to Microtubule Destabilization via GSK-3\u03b2-Dependent Tau Phosphorylation in PC12 Cells. Paudel HK, editor. PLoS One. 2014;9:e94259 Public Library of Science","DOI":"10.1371\/journal.pone.0094259"},{"key":"624_CR16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","volume":"10","author":"RL Hamilton","year":"2000","unstructured":"Hamilton RL (2000) Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10:378\u2013384","journal-title":"Brain Pathol"},{"key":"624_CR17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/00005072-199311000-00012","volume":"52","author":"LA Hansen","year":"1993","unstructured":"Hansen LA, Masliah E, Galasko D, Terry RD (1993) Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa. J Neuropathol Exp Neurol 52:648\u2013654","journal-title":"J Neuropathol Exp Neurol"},{"key":"624_CR18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D et al (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain 133:713\u2013726 Oxford University Press","journal-title":"Brain"},{"key":"624_CR19","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM-Y, Trojanowski JQ (2013) Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies. Nat Rev Neurosci NIH Public Access 14:626\u2013636","journal-title":"Nat Rev Neurosci NIH Public Access"},{"key":"624_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L (1995) Rohan de Silva H., et al. the precursor protein of non-A\u03b2 component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14:467\u2013475","journal-title":"Neuron"},{"key":"624_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jalz.2010.03.004","volume":"6","author":"CR Jack","year":"2010","unstructured":"Jack CR, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM et al (2010) Update on the magnetic resonance imaging core of the Alzheimer\u2019s disease neuroimaging initiative. Alzheimers Dement 6:212\u2013220 NIH Public Access","journal-title":"Alzheimers Dement"},{"key":"624_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/jmri.21049","volume":"27","author":"CR Jack","year":"2008","unstructured":"Jack CR, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D et al (2008) The Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27:685\u2013691 NIH Public Access","journal-title":"J Magn Reson Imaging"},{"key":"624_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1750-1326-2-6","volume":"2","author":"V Kallhoff","year":"2007","unstructured":"Kallhoff V, Peethumnongsin E, Zheng H (2007) Lack of \u03b1-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer\u2019s disease. Mol Neurodegener BioMed Central 2:6","journal-title":"Mol Neurodegener BioMed Central"},{"key":"624_CR24","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jnnp.2009.197483","volume":"81","author":"K Kasuga","year":"2010","unstructured":"Kasuga K, Tokutake T, Ishikawa A, Uchiyama T, Tokuda T, Onodera O et al (2010) Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 81:608\u2013610 BMJ Publishing Group Ltd","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10.1111","key":"624_CR25","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1111\/j.1742-4658.2011.08389.x","volume":"278","author":"F Kawakami","year":"2011","unstructured":"Kawakami F, Suzuki M, Shimada N, Kagiya G, Ohta E, Tamura K et al (2011) Stimulatory effect of \u03b1-synuclein on the tau-phosphorylation by GSK-3\u03b2. FEBS J 278(10.1111):4895\u20134904 Wiley\/Blackwell","journal-title":"FEBS J"},{"key":"624_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3233\/JAD-130458","volume":"36","author":"A Korff","year":"2013","unstructured":"Korff A, Liu C, Ginghina C, Shi M, Zhang J (2013) \u03b1-Synuclein in cerebrospinal fluid of Alzheimer\u2019s disease and mild cognitive impairment. J Alzheimer\u2019s Dis 36:679\u2013688 IOS Press","journal-title":"J Alzheimer\u2019s Dis"},{"key":"624_CR27","doi-asserted-by":"publisher","first-page":"E4648","DOI":"10.1073\/pnas.1704698114","volume":"114","author":"ME Larson","year":"2017","unstructured":"Larson ME, Greimel SJ, Amar F, LaCroix M, Boyle G, Sherman MA et al (2017) Selective lowering of synapsins induced by oligomeric \u03b1-synuclein exacerbates memory deficits. Proc Natl Acad Sci 114:E4648\u2013E4657 National Academy of Sciences","journal-title":"Proc Natl Acad Sci"},{"key":"624_CR28","doi-asserted-by":"publisher","first-page":"10253","DOI":"10.1523\/JNEUROSCI.0581-12.2012","volume":"32","author":"ME Larson","year":"2012","unstructured":"Larson ME, Sherman MA, Greimel S, Kuskowski M, Schneider JA, Bennett DA et al (2012) Soluble alpha-Synuclein is a novel modulator of Alzheimer\u2019s disease pathophysiology. J Neurosci 32:10253\u201310266","journal-title":"J Neurosci"},{"key":"624_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archneur.63.3.370","volume":"63","author":"JB Leverenz","year":"2006","unstructured":"Leverenz JB, Fishel MA, Peskind ER, Montine TJ, Nochlin D, Steinbart E et al (2006) Lewy Body Pathology in Familial Alzheimer Disease. Arch Neurol 63:370 American Medical Association","journal-title":"Arch Neurol"},{"key":"624_CR30","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1212\/01.WNL.0000128089.53030.AC","volume":"62","author":"YJ Li","year":"2004","unstructured":"Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ et al (2004) Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology 62:2005\u20132009","journal-title":"Neurology"},{"key":"624_CR31","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0002-9440(10)65722-7","volume":"153","author":"CF Lippa","year":"1998","unstructured":"Lippa CF, Fujiwara H, Mann DMA, Giasson B, Baba M, Schmidt ML et al (1998) Lewy bodies contain altered \u03b1-Synuclein in brains of many familial Alzheimer\u2019s disease patients with mutations in Presenilin and amyloid precursor protein genes. Am J Pathol 153:1365\u20131370","journal-title":"Am J Pathol"},{"key":"624_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu C-C, Liu C-C, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106\u2013118 NIH Public Access","journal-title":"Nat Rev Neurol"},{"key":"624_CR33","first-page":"201","volume":"148","author":"E Masliah","year":"1996","unstructured":"Masliah E, Iwai A, Mallory M, U\u00e9da K, Saitoh T (1996) Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer\u2019s disease. Am J Pathol 148:201\u2013210 American Society for Investigative Pathology","journal-title":"Am J Pathol"},{"key":"624_CR34","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology 34:939\u2013944 American Academy of Neurology","journal-title":"Neurology"},{"key":"624_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:263\u2013269 Elsevier","journal-title":"Alzheimers Dement"},{"key":"624_CR36","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","volume":"67","author":"MA Mintun","year":"2006","unstructured":"Mintun MA, LaRossa GN, Sheline YI, Dence CS, Lee SY, Mach RH et al (2006) [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease. Neurology 67:446\u2013452","journal-title":"Neurology"},{"key":"624_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","volume":"213","author":"B Mollenhauer","year":"2008","unstructured":"Mollenhauer B, Cullen V, Kahn I, Krastins B, Outeiro TF, Pepivani I et al (2008) Direct quantification of CSF \u03b1-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol 213:315\u2013325 Academic Press","journal-title":"Exp Neurol"},{"key":"624_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","volume":"213","author":"B Mollenhauer","year":"2008","unstructured":"Mollenhauer B, Cullen V, Kahn I, Krastins B, Outeiro TF, Pepivani I et al (2008) Direct quantification of CSF \u03b1-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol 213:315\u2013325","journal-title":"Exp Neurol"},{"key":"624_CR39","first-page":"230","volume":"10","author":"B Mollenhauer","year":"2011","unstructured":"Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-D\u00f6ring F, Trenkwalder C, Schlossmacher MG (2011) \u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol. Elsevier 10:230\u2013240","journal-title":"Elsevier"},{"key":"624_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM et al (2010) APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 67:122\u2013131 NIH Public Access","journal-title":"Ann Neurol"},{"key":"624_CR41","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S1474-4422(17)30074-1","volume":"16","author":"C Mueller","year":"2017","unstructured":"Mueller C, Ballard C, Corbett A, Aarsland D (2017) The prognosis of dementia with Lewy bodies. Lancet Neurol 16:390\u2013398","journal-title":"Lancet Neurol"},{"issue":"4","key":"624_CR42","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/mds.27297","volume":"33","author":"K Ogaki","year":"2018","unstructured":"Ogaki K, Martens YA, Heckman MG, Koga S, Labb\u00e9 C, Lorenzo-Betancor O et al (2018) Multiple system atrophy and apolipoprotein E. Mov Disord 33(4):647\u2013650","journal-title":"Mov Disord"},{"key":"624_CR43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neulet.2008.11.015","volume":"450","author":"A \u00d6hrfelt","year":"2009","unstructured":"\u00d6hrfelt A, Grognet P, Andreasen N, Wallin A, Vanmechelen E, Blennow K et al (2009) Cerebrospinal fluid \u03b1-synuclein in neurodegenerative disorders\u2014a marker of synapse loss? Neurosci Lett 450:332\u2013335 Elsevier","journal-title":"Neurosci Lett"},{"key":"624_CR44","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41467-017-01150-x","volume":"8","author":"S Palmqvist","year":"2017","unstructured":"Palmqvist S, Sch\u00f6ll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H et al (2017) Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun 8:1214 Nat Nature Publishing Group","journal-title":"Nat Commun"},{"key":"624_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13195-018-0336-4","volume":"10","author":"K Patra","year":"2018","unstructured":"Patra K, Soosaipillai A, Sando SB, Lauridsen C, Berge G, M\u00f8ller I et al (2018) Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer\u2019s disease. Alzheimers Res Ther 10:9 BioMed Central","journal-title":"Alzheimers Res Ther"},{"key":"624_CR46","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2004.10.006","volume":"26","author":"O Pletnikova","year":"2005","unstructured":"Pletnikova O, West N, Lee MK, Rudow GL, Skolasky RL, Dawson TM et al (2005) A\u03b2 deposition is associated with enhanced cortical \u03b1-synuclein lesions in Lewy body diseases. Neurobiol Aging 26:1183\u20131192","journal-title":"Neurobiol Aging"},{"key":"624_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-8-20","volume":"8","author":"C Ros\u00e9n","year":"2013","unstructured":"Ros\u00e9n C, Hansson O, Blennow K, Zetterberg H (2013) Fluid biomarkers in Alzheimer\u2019s disease \u2013 current concepts. Mol Neurodegener 8:20","journal-title":"Mol Neurodegener"},{"key":"624_CR48","first-page":"904","volume":"39","author":"OG Rousset","year":"1998","unstructured":"Rousset OG, Ma Y, Evans AC (1998) Correction for partial volume effects in PET: principle and validation. J Nucl Med 39:904\u2013911","journal-title":"J Nucl Med"},{"key":"624_CR49","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.nucmedbio.2005.05.002","volume":"32","author":"DJ Rowland","year":"2005","unstructured":"Rowland DJ, Garbow JR, Laforest R, Snyder AZ, Xu S, Zanzonico PB et al (2005) Registration of [18F]FDG microPET and small-animal MRI. Nucl Med Biol 32:567\u2013572 Elsevier","journal-title":"Nucl Med Biol"},{"key":"624_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-017-0162-3","volume":"12","author":"L Saint-Aubert","year":"2017","unstructured":"Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A (2017) Tau PET imaging: present and future directions. Mol Neurodegener 12:19 BioMed Central","journal-title":"Mol Neurodegener"},{"key":"624_CR51","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1074\/jbc.M111.277061","volume":"287","author":"S Saman","year":"2012","unstructured":"Saman S, Kim W, Raya M, Visnick Y, Miro S, Saman S et al (2012) Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem 287:3842\u20133849 American Society for Biochemistry and Molecular Biology","journal-title":"J Biol Chem"},{"key":"624_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/mt.2012.66","volume":"21","author":"B Spencer","year":"2013","unstructured":"Spencer B, Michael S, Shen J, Kosberg K, Rockenstein E, Patrick C et al (2013) Lentivirus mediated delivery of neurosin promotes clearance of wild-type \u03b1-synuclein and reduces the pathology in an \u03b1-synuclein model of LBD. Mol Ther 21:31\u201341 Elsevier","journal-title":"Mol Ther"},{"key":"624_CR53","doi-asserted-by":"publisher","first-page":"e0152082","DOI":"10.1371\/journal.pone.0152082","volume":"11","author":"Y Su","year":"2016","unstructured":"Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N et al (2016) Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer\u2019s Disease: Results from the DIAN Study Group. PLoS One 11:e0152082 Herholz K, editor. Public Library of Science","journal-title":"PLoS One"},{"key":"624_CR54","doi-asserted-by":"publisher","first-page":"e73377","DOI":"10.1371\/journal.pone.0073377","volume":"8","author":"Y Su","year":"2013","unstructured":"Su Y, D\u2019Angelo GM, Vlassenko AG, Zhou G, Snyder AZ, Marcus DS et al (2013) Quantitative Analysis of PiB-PET with FreeSurfer ROIs. PLoS One 8:e73377 Chen K, editor. Public Library of Science","journal-title":"PLoS One"},{"key":"624_CR55","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neures.2010.04.008","volume":"67","author":"H Tatebe","year":"2010","unstructured":"Tatebe H, Watanabe Y, Kasai T, Mizuno T, Nakagawa M, Tanaka M et al (2010) Extracellular neurosin degrades \u03b1-synuclein in cultured cells. Neurosci Res 67:341\u2013346 Elsevier","journal-title":"Neurosci Res"},{"key":"624_CR56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/WAD.0b013e31823899cc","volume":"26","author":"F Tateno","year":"2012","unstructured":"Tateno F, Sakakibara R, Kawai T, Kishi M, Murano T (2012) Alpha-synuclein in the cerebrospinal fluid differentiates Synucleinopathies (Parkinson disease, dementia with Lewy bodies, multiple system atrophy) from Alzheimer disease. Alzheimer Dis Assoc Disord 26:213\u2013216","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"624_CR57","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","volume":"349","author":"T Tokuda","year":"2006","unstructured":"Tokuda T, Salem SA, Allsop D, Mizuno T, Nakagawa M, Qureshi MM et al (2006) Decreased \u03b1-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson\u2019s disease. Biochem Biophys Res Commun 349:162\u2013166 Academic Press","journal-title":"Biochem Biophys Res Commun"},{"key":"624_CR58","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","volume":"90","author":"K U\u00e9da","year":"1993","unstructured":"U\u00e9da K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M et al (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 90:11282\u201311286","journal-title":"Proc Natl Acad Sci U S A"},{"key":"624_CR59","doi-asserted-by":"publisher","unstructured":"Vergallo A, Bun R-S, Toschi N, Baldacci F, Zetterberg H, Blennow K et al (2018) Association of cerebrospinal fluid \u03b1-synuclein with total and phospho-tau 181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer\u2019s disease biomarkers. Alzheimers Dement:1\u20139. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2018.06.3053\n                    \n                  .","DOI":"10.1016\/j.jalz.2018.06.3053"},{"key":"624_CR60","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3233\/JAD-171013","volume":"61","author":"H Wang","year":"2018","unstructured":"Wang H, Stewart T, Toledo JB, Ginghina C, Tang L, Atik A et al (2018) A longitudinal study of Total and phosphorylated \u03b1-Synuclein with other biomarkers in cerebrospinal fluid of Alzheimer\u2019s disease and mild cognitive impairment. J Alzheimer\u2019s Dis 61:1541\u20131553 IOS Press","journal-title":"J Alzheimer\u2019s Dis"},{"key":"624_CR61","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/JAD-2012-111655","volume":"29","author":"M Wennstr\u00f6m","year":"2012","unstructured":"Wennstr\u00f6m M, Londos E, Minthon L, Nielsen HM (2012) Altered CSF orexin and \u03b1-synuclein levels in dementia patients. J Alzheimers Dis 29:125\u2013132","journal-title":"J Alzheimers Dis"},{"key":"624_CR62","doi-asserted-by":"publisher","first-page":"e53250","DOI":"10.1371\/journal.pone.0053250","volume":"8","author":"M Wennstr\u00f6m","year":"2013","unstructured":"Wennstr\u00f6m M, Surova Y, Hall S, Nilsson C, Minthon L, Bostr\u00f6m F et al (2013) Low CSF levels of both \u03b1-synuclein and the \u03b1-synuclein cleaving enzyme neurosin in patients with synucleinopathy. PLoS One 8:e53250 Public Library of Science","journal-title":"PLoS One"},{"key":"624_CR63","first-page":"240","volume-title":"Mild cognitive impairment \u2013 beyond controversies, towards a consensus\u00a0: report of the International Working Group on Mild Cognitive Impairment","author":"B Winblad","year":"2004","unstructured":"Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L (2004) Mild cognitive impairment \u2013 beyond controversies, towards a consensus\u00a0: report of the International Working Group on Mild Cognitive Impairment, pp 240\u2013246"},{"key":"624_CR64","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1093\/brain\/awu119","volume":"137","author":"AR Winslow","year":"2014","unstructured":"Winslow AR, Moussaud S, Zhu L, Post KL, Post KL, Dickson DW et al (2014) Convergence of pathology in dementia with Lewy bodies and Alzheimer\u2019s disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease. Brain Oxford 137:1958\u20131970 University Press","journal-title":"Brain Oxford"},{"key":"624_CR65","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1097\/00001756-200011270-00029","volume":"11","author":"O Wirths","year":"2000","unstructured":"Wirths O, Weickert S, Majtenyi K, Havas L, Kahle PJ, Okochi M et al (2000) Lewy body variant of Alzheimer\u2019s disease: alpha-synuclein in dystrophic neurites of a beta plaques. Neuroreport 11:3737\u20133741","journal-title":"Neuroreport"},{"key":"624_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D (2017) \u0391-Synuclein Toxicity in Neurodegeneration: Mechanism and Therapeutic Strategies. Nat Med 23:1\u201313 Nature Publishing Group","journal-title":"Nat Med"},{"key":"624_CR67","doi-asserted-by":"publisher","first-page":"e68910","DOI":"10.1371\/journal.pone.0068910","volume":"8","author":"M Xia","year":"2013","unstructured":"Xia M, Wang J, He Y (2013) BrainNet Viewer: A Network Visualization Tool for Human Brain Connectomics. PLoS One 8:e68910 Csermely P, editor. Public Library of Science","journal-title":"PLoS One"},{"issue":"10.1111","key":"624_CR68","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/ene.12326","volume":"21","author":"H Zetterberg","year":"2014","unstructured":"Zetterberg H, Petzold M, Magdalinou N (2014) Cerebrospinal fluid \u03b1-synuclein levels in Parkinson\u2019s disease - changed or unchanged? Eur J Neurol 21(10.1111):365\u2013367 Wiley\/Blackwell","journal-title":"Eur J Neurol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0624-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0624-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0624-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T15:09:11Z","timestamp":1589555351000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0624-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0624-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"23 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research aims pursued in the longitudinal cohort were approved by the regional ethics committee in Trondheim, Norway (2010\/226) and Stockholm, Sweden (2016\/771\u201331\/4). The described studies relating to the DIAN cohort wereapproved by the local ethics committee in Stockholm, Sweden (2016\/2114\u201331\/4). The studies of both cohorts were carried out in agreement with the Helsinki Declaration.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"130"}}